Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
Cancer and Neuroscience Led 2023 VC, M&A Investment in Biopharma
BioSpace
Wed, 02/14/24 - 11:36 am
funding
M&A
venture capital
cancer
Neuroscience
ProfoundBio secures $112m to advance ADC portfolio for cancer
Pharmaceutical Business Review
Wed, 02/14/24 - 10:52 am
ProfoundBio
funding
cancer
antibody-drug conjugate
Was Pfizer’s “Here’s to Science” commercial during the Super Bowl a winning play or a fumble?
Stat
Mon, 02/12/24 - 11:09 pm
Pfizer
pharma advertising
Super Bowl
oncology
cancer
As cancer drug shortages persist, ASCO official urges congressional action at hearing
Fierce Pharma
Fri, 02/9/24 - 11:16 am
cancer
drug shortages
chemotherapy
US Congress
ASCO
Sanofi guarantees employees one year of salary and support after cancer diagnosis
Fierce Pharma
Tue, 02/6/24 - 09:38 am
Sanofi
cancer
employees
employee benefits
Novartis in the lead to acquire cancer drug developer MorphoSys-sources
NASDAQ.com/Reuters
Mon, 02/5/24 - 11:28 am
Novartis
M&A
MorphoSys
cancer
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
FDA Reveals More Details on 22 CAR-T Secondary Cancer Cases
BioSpace
Thu, 01/25/24 - 11:03 am
CAR-T
cancer
FDA
CG Oncology prices larger-than-expected $380M IPO in hopeful sign for biotech
BioPharma Dive
Wed, 01/24/24 - 11:36 pm
CG Oncology
IPOs
cancer
oncology
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Synnovation Therapeutics
Incyte
AstraZeneca
GSK
Novartis
Pfizer
funding
cancer
PARP inhibitors
Next stage in GSK’s Zantac defense gets underway today
Pharmaphorum
Mon, 01/22/24 - 11:13 am
GSK
Zantac
legal
cancer
Study finds hundreds of overlooked cancer drug targets
Pharmaphorum
Fri, 01/12/24 - 09:42 am
cancer
oncology
drug discovery
Wellcome Sanger Institute
JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals
Fierce Pharma
Thu, 01/11/24 - 11:34 am
Pfizer
oncology
cancer
antibody-drug conjugate
JPMHC 2024
C4 lays off 30% of staff in aftermath of BRD9 degrader discontinuation
Fierce Biotech
Wed, 01/10/24 - 09:35 am
C4 Therapeutics
cancer
layoffs
Cancer biotech ArriVent Biopharma files for a $100 million IPO
Renaissance Capital
Mon, 01/8/24 - 11:38 am
ArriVent Biopharma
IPOs
cancer
Allogene to shift strategy in bid to reposition CAR-T
BioPharma Dive
Fri, 01/5/24 - 10:03 am
Allogene Therapeutics
cell therapy
cancer
CAR-T
Galapagos wants to find new small molecule species for cancer with BridGene
Fierce Biotech
Wed, 01/3/24 - 05:05 pm
BridGene Biosciences
Galapagos
cancer
small molecule drugs
Market for CAR-Ts Still Bright Despite FDA Cancer Safety Review
BioSpace
Wed, 12/20/23 - 09:36 am
CAR-T
FDA
cancer
Oncologists Defend CAR-T After FDA Advisory
BioSpace
Mon, 12/18/23 - 10:11 am
oncologists
CAR-T
cancer
FDA
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
BioSpace
Fri, 12/15/23 - 09:43 am
Bicycle Therapeutics
cancer
R&D
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »